Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases | Science Immunology
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Blockade of the PD-1/PD-L1 interaction by the anti-PD-L1 peptides and... | Download Scientific Diagram
Anti-Mouse PD-1 Antibody (RMP1-14), In Vivo Grade | Leinco
Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Frontiers | A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy
PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments - Polesso - 2021 - European Journal of Immunology - Wiley Online Library